CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZN

Laroprovstat/Rosuvastatin 1

Phase 3
AstraZeneca PLC (AZN)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
AZNPhase 3

Laroprovstat/Rosuvastatin 1 Phase 3 Est. Readout

Laroprovstat/Rosuvastatin 1
Q3 2027~Q
CT.gov
00%
Competitive Landscape

0 competitors in Hypercholesterolaemia

View Full Landscape
Drug Information

Target Indication

Hypercholesterolaemia

Clinical Trial

NCT07619131

Last updated: 11/5/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.